Exelixis
Healthcare & Life Sci
Company overview
Exelixis is an oncology-focused pharmaceutical company. Its approved drug Cabometyx, known by the generic name cabozantinib, treats multiple types of cancer. The company also develops bispecific antibodies and antibody-drug conjugates for cancer treatment. Exelixis was founded in November 1994 and is headquartered in Alameda, California. Historically, the median salary is ~$209,250. Exelixis is a top-tier H-1B sponsor.
- Industry
- Healthcare & Life Sci
- Headquarters
- Alameda, United States